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ABSTRACT
Introduction Self- management support can enable and 
empower people living with and beyond cancer to take 
an active role in managing long- term consequences of 
cancer treatment. Healthcare professionals are key to 
promoting patients to self- manage, however, they do 
not routinely engage in these discussions. This review 
aims to understand what works for whom and in what 
circumstances in relation to practitioners engaging with 
supporting people living with and beyond cancer to self- 
manage long- term consequences of systemic anticancer 
treatment.
Methods and analysis We will follow five steps for 
undertaking the realist review: (1) define the review 
scope, (2) develop initial programme theories, (3) evidence 
search, (4) selection and appraisal and (5) data extraction 
and synthesis. We will combine an informal literature 
search with a theory- based approach, using the theoretical 
domains framework, and stakeholder feedback to develop 
initial programme theories. We will search Medline, 
EMBASE, CINAHL, Scopus, PsycINFO, ERIC and AMED 
databases to September 2019, and supplement this with 
citation tracking, grey literature and practitioner surveys. 
Data selection will be based on relevance and rigour. 
Data will be extracted and synthesised iteratively, and 
causal links between contexts, mechanism and outcomes 
illuminated in the process. The results will be reported 
according to the Realist And Meta- narrative Evidence 
Syntheses: Evolving Standards quality and publication 
standards.
Ethics and dissemination We have received ethical 
approval through the Research Ethics Committee, Faculty 
of Medicine and Health Sciences, University of East Anglia 
(ref 2 01 819-124). We will disseminate to the research 
community through conference presentations and a peer- 
reviewed journal article. We will work with healthcare 
organisations, cancer charities and patients to agree a 
strategy for disseminating to these groups.
PROSPERO registration number CRD42019120910.
INTRODUCTION
The global cancer incidence in 2018 was 
estimated at 18 million new cases and over 
9 million deaths,1 costing an estimated £115 
billion.2 The global cancer burden is putting 
significant physical, financial and emotional 
strain on people living with cancer and their 
families. At the same time, coping with the 
growing demand for cancer care is becoming 
untenable for healthcare systems in high- 
income, middle- income and low- income 
countries. This is due to increasing treatment 
complexity, rising healthcare costs and a 
shrinking healthcare workforce.2–4
In the UK, a growing and ageing popula-
tion, earlier detection strategies and newer 
and more effective targeted treatment 
options are leading to increasing numbers 
of adults being diagnosed with and living 
beyond cancer. The number of people living 
with and beyond cancer is predicted to grow 
from 2.9 million in 2020 to 5.3 million in 
2040 of whom more than 70% will be over 65 
years.5 It is estimated that about one in three 
adults will be living with the long- term conse-
quences of cancer treatment, which can last 
for years after cancer treatment.6 Systemic 
anticancer therapy is one type of cancer treat-
ment. Choice of systemic anticancer therapy 
Strengths and limitations of this study
 ► The realist review addresses a policy initiative in the 
UK to promote self- management among people liv-
ing with and beyond cancer.
 ► The methodological approach of combining pub-
lished with survey data is novel to a realist review.
 ► Using the theoretical domains framework is a novel 
approach for the initial development and contin-
uous refinement of programme theories in realist 
methods.
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can vary depending on cancer type and whether treat-
ment is intended to be curative or palliative and includes 
chemotherapy, hormonal therapy, targeted therapy, such 
as small- molecule drugs or monoclonal antibodies, and 
immunotherapy. While advances in systemic anticancer 
therapy have led to improvements in survival, a significant 
proportion of people living with and beyond cancer will 
experience long- term problems associated with systemic 
anticancer therapy.7–9 The consequences can be both 
physical, such as urinary and bowel problems, pain and 
chronic fatigue, and psychosocial, such as fear of cancer 
recurrence, depression, negative body image and issues 
with relationships.
Self- management involves the actions taken by 
patients to recognise, treat and manage their long- term 
health conditions.10 This may include physical activity 
to improve fatigue, self- medication to manage pain and 
attending self- help groups for information and emotional 
support. Self- management therefore requires patients to 
be an active partner in their healthcare. A large body of 
research has evolved to investigate and address patient 
barriers and enablers to self- managing long- term condi-
tions.11–13 Enablers include increasing patient confidence, 
a person- centred approach and a collaborative partner-
ship between patients and healthcare providers. Despite 
primary and secondary care practitioners, such as doctors, 
nurses, pharmacists and allied health professionals 
having a key role in supporting patient self- management, 
implementation of this supportive role beyond research 
studies is limited.14 15 Practitioners providing cancer 
care do not routinely provide self- management support 
to people living with and beyond cancer. This is likely 
due to lack of clarity around optimal implementation 
approaches.16 Application of behaviour change theory 
may help to better understand the barriers and enablers 
to practitioners implementing self- management support 
and addressing these through relevant behaviour change 
techniques.17 Furthermore, identifying intervention 
components that will maintain effectiveness beyond the 
research phases requires an understanding of why inter-
vention components work and how its efficacy is influ-
enced by contextual factors such as available resources 
and training.18
Realist reviews use theory to explore how context 
such as cultural norms and values, economic conditions, 
geographic characteristics or national policy interacts 
with various mechanisms to produce outcomes. Further, 
a realist review can produce important information 
about the relative effectiveness of intervention compo-
nents, thereby enabling practitioners, researchers and 
service providers to design and implement interventions 
comprising only effective components for particular 
contexts.
With self- management as a key strategy for ensuring 
personalised care for people living with and beyond 
cancer,19 20 this review will be timely in building the 
evidence base to identify the principles for changing prac-
titioners’ knowledge, attitudes and behaviour to facilitate 
engagement with and delivery of self- management support 
interventions. We will focus on interventions designed to 
support patients living with and beyond cancer to self- 




A realist review is an interpretative theory- driven approach 
to synthesise evidence using multiple sources such as 
published studies, policy documents and grey literature.21 
The realist approach acknowledges that interventions 
may work in some contexts but not others. This notion 
of interventions being context- bound is a key principle of 
the realist approach. A realist review focuses on causation 
and is represented as context+mechanism=outcome.22
Context refers to the ‘backdrop’ conditions that have 
an impact on outcomes, such as the way services are 
configured to facilitate practitioners to support self- 
management by patients. Other examples of context 
include cultural norms and values, pre- existing relation-
ships/rapport between practitioners and patients and 
funding sources. Context can be understood as any condi-
tion that triggers or modifies a mechanism.23 A mecha-
nism is the causal force, triggered in particular contexts, 
that leads to outcomes. Mechanisms explain why and how 
observed outcomes occur and usually comprise two parts: 
the ‘resources’ offered by an intervention and the cogni-
tive or emotional decisions (‘reasoning’) and behaviour 
of people.24 Examples of ‘resources’ include practitioner 
information or advice and examples of ‘reasoning’ include 
trust between practitioner and patient and increased prac-
titioner confidence to provide self- management support. 
Outcomes are the intended or unintended effects of the 
intervention, which are based on the interaction between 
the context and mechanism. Some examples of outcomes 
include patient engagement with self- management activ-
ities and practitioners formulating an individualised self- 
management action plan with the patient.
A realist review begins with programme theories which 
describe a theoretical relationship between contexts, 
mechanisms and outcomes. Use of formal theory from 
disciplines such as sociology and behavioural science 
has emerged as a strategy to providing a framework for 
the initial generation of programme theories.25 These 
programme theories are then tested against empirical 
evidence to explain ‘How does it work?’, ‘Why does it 
work?’, ‘For whom does it work?’ and ‘In what circum-
stances does it work?’21
This testing is an iterative process of examining evidence 
to develop ideas which is termed abductive reasoning,26 
together with illuminating the causal links between 
contexts, mechanisms and outcomes termed retroduc-
tion.27 This process results in a middle- range theory to 
explain how the interventions included in the review work. 
The middle- range theory is sufficiently broad to allow 
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that can be used to design and implement interventions 
within complex environments.27 Stakeholder engagement 
throughout the review process is encouraged to ensure 
inclusion of multiple perspectives.22 Reporting standards 
for realist reviews and evaluation have been developed,29 
however, specified methods for conducting realist reviews 
are variable.22 26 30
The main research question guiding this review is:
What works for whom and in what circumstances in 
relation to practitioners supporting people living with 
and beyond cancer to self- manage the long- term physical 
and psychosocial consequences on completing systemic 
anticancer therapies?
Pawson et al have proposed a method for conducting 
realist reviews.21 However, there is freedom to interpret 
the method and customise the steps.22 26 29 This review 
is guided by five steps, adapted from Pawson et al for 
conducting a realist review: (1) define the review scope, 
(2) develop initial programme theories, (3) search for 
evidence, (4) select and appraise evidence and (5) extract 
and synthesise data.21 Figure 1 provides an overview of 
the review design. Steps are shown sequentially, however, 
as the process of undertaking a realist review is iterative, 
steps may overlap or proceed in parallel as the review 
progresses. We will report the study results according 
to the Realist And Meta- narrative Evidence Syntheses: 
Evolving Standards (RAMESES) quality and publication 
standards.30
Step 1: define the review scope
A realist review starts by clarifying the scope of the review 
and developing initial programme theories, which provide 
the scaffolding for evidence synthesis.21 We undertook a 
preliminary literature search to identify the existing liter-
ature about influences on practitioners promoting self- 
management among patients and how self- management 
support interventions seek to address the needs of 
people living with and beyond cancer. We started by 
looking at systematic reviews of self- management and self- 
management support in adults living with and beyond 
cancer. To identify relevant reviews, we searched PubMed 
and The Cochrane Library, using the following search 
terms: cancer survivors, healthcare professionals and 
self- management or self- care. In addition, we undertook 
keyword searches on Google Scholar and the National 
Institute for Health and Care Excellence Evidence search 
for reviews and primary studies on self- management 
support in the cancer setting and we reviewed national 
and international cancer policy documents.4 31–33
The preliminary search informed the construction of 
an overarching framework (figure 2). We drew mainly on 
the UK31 32 and the USA4 33 recommendations to improve 
the care of people living with and beyond cancer and the 
experiential knowledge of the review team. We identified 
the key issues faced by people who had completed cancer 
treatment and strategies proposed in the UK to address 
peoples’ needs. The framework highlights key unmet 
needs of people post cancer treatment: dealing with the 
physical and psychosocial consequences of cancer treat-
ment and negotiating the multiple cancer services offered 
within the healthcare system as seen in figure 2. The 
framework shows the influences on the unmet needs of 
people at a policy level. The framework sets out changes 
Figure 1 Overview of realist review design. TDF, theoretical 
domains framework.
Figure 2 Framework of the influences on unmet needs of 
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needed in cancer services and the healthcare workforce to 
facilitate a shift from a medical- led approach to one that 
empowers people living with and beyond cancer to take 
on a more active role to self- manage the consequences of 
cancer treatment, with support from practitioners.
The realist review questions which emerged from the 
preliminary search were:
1. What are the determinants (barriers and enablers) of 
practitioners delivering interventions to support self- 
management by people living with and beyond cancer?
2. What are the key components, practitioner skills and 
behaviours needed to implement self- management 
support interventions among people living with and 
beyond cancer?
3. What are the intended and unintended outcomes for 
patients, organisations or the wider healthcare system 
of interventions which target practitioner delivery of 
self- management support?
4. What are the mechanisms by which interventions tar-
geting practitioner delivery of self- management sup-
port result in their outcomes?
5. What are the contexts that influence mechanisms in-
volved in interventions targeting practitioner delivery 
of self- management support?
Step 2: develop initial programme theories
Programme theories are abstract descriptions of the 
content or components of interventions and how they 
are assumed to cause intended or observed outcomes.25 
Realist programme theories illustrate the relation-
ship between contexts, mechanisms and outcomes. 
They are expressed as context–mechanism–outcome 
configurations (CMOCs). Figure 3 shows hypothesised 
CMOCs using self- management support as an example. 
Various methods are used to articulate and build initial 
programme theories, such as extracting implicit theo-
ries from empirical evidence or stakeholders and using 
concepts from a priori formal theories. Given the hetero-
geneity and abundance of formal theories, selection 
of appropriate theories for realist reviews can be chal-
lenging. Using a framework that incorporates a wide 
range of theories could provide a broad lens to identify 
influences on programme delivery.25
We will structure ideas about programme theories 
developed from our preliminary search in step 1, with 
the theoretical domains framework (TDF). This frame-
work was developed by experts from multiple disciplines, 
including behavioural science and implementation 
science and is widely used in healthcare to identify barriers 
and facilitators of practitioner behaviour change.34 35 The 
TDF is a synthesis of 128 constructs from 33 theories 
of behaviour change clustered into 14 domains: knowl-
edge, skills, social/professional role and identity, beliefs 
about capabilities, optimism, reinforcement, intentions, 
goals, memory, attention and decision processes, environ-
mental context and resources, social influences, emotion, 
and behavioural regulation.34 Figure 3 includes the TDF 
domains for the hypothesised CMOCs.
Benefits of using the TDF to build initial programme 
theories include: identification of a broad range of 
influences on practitioner behaviour to support self- 
management in people living with cancer than would 
be possible using empirical evidence alone; exploration 
of the influence of context at different levels such as 
individual, team, organisational and system; and provi-
sion of a structured, yet flexible, approach to building 
programme theories.
We will seek the help of stakeholders to review and 
prioritise a maximum of 10 initial programme theories to 
test against the literature. Stakeholders will be recruited 
from existing cancer support and research groups known 
to the researchers. Membership of the groups includes 
people living with and beyond cancer, caregivers, practi-
tioners, healthcare purchasers, that is, commissioners and 
members of cancer advocacy groups such as cancer char-
ities. Stakeholders will prioritise the initial programme 
theories using a two- step process: by completing an online 
survey to identify what they perceive to be important 
about how self- management programmes delivered by 
practitioners such as nurses, doctors, allied health profes-
sionals and pharmacists to support people with cancer 
worked, and during a face- to- face workshop to identify 
up to a maximum of 10 initial programme theories for 
further testing.
The review team will select programme theories for 
further discussion, based on an a priori criterion of 70% 
stakeholder agreement.36 Initial programme theories will 
be prioritised as follows: if 100% of survey participants 
agree that the theory is important it will be selected for 
testing. If 70%–99% of survey participants agree that the 
theory is important it will be discussed at a workshop. 
If less than 70% of participants agree that the theory is 
important it will not be selected.
Step 3: evidence search
This step will involve the identification of suitable papers 
to test and refine the initial programme theories selected 
Figure 3 Hypothetical self- management support 
programme theory illustrating context–mechanism–outcome 
configurations. Grey boxes represent TDF domains. SM, 
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in step 2. We will search the following electronic data-
bases, to September 2019: Medline, EMBASE, CINAHL, 
Scopus, PsycINFO, ERIC and AMED. Search terms will be 
developed in discussion with the review team (see online 
supplementary file for an example of Medline search).
In addition, we will undertake the following to identify 
relevant evidence from a range of sources for inclusion 
in the review:
 ► Check reference lists from primary studies and system-
atic reviews (snowballing).
 ► Citation searches, for example, using the ‘Cited 
by’ option on Scopus and Google Scholar (lateral 
searching).
 ► Seek input from the review team to uncover other 
relevant publications, guidelines or policies.
 ► Seek input from stakeholders representing practi-
tioners, such as doctors, nurses and pharmacists, and 
commissioners of self- management support inter-
ventions for people living with cancer, via an online 
survey.
Table 1 reports the inclusion and exclusion criteria we 
have developed to focus the review, but these will likely be 
refined as the review progresses.
We acknowledge that further iterative searches may 
be needed as the review progresses. This will involve 
purposive searching for evidence to support or refute the 
initial or emerging programme theories.
The traditional data source for realist reviews is 
secondary data from published documents. This approach 
dominates realist literature and is useful for exploring 
interventions that have limited published real- world data. 
In such instances, reviewers use data from related inter-
ventions. Where interventions are widely implemented, 
combining real- world experience with published data 
may provide clearer insights into the mechanisms that 
operate in particular contexts to produce outcomes. 
We will develop an online survey to capture real- world 
data of interventions which target practitioner delivery 
of self- management support in any healthcare setting. 
We will adopt the strategies used for conducting realist 
qualitative interviews to develop our realist theory- driven 
survey questions.37 Survey questions will be open- ended, 
producing qualitative data. We will use a purposive 
sampling approach to identify potential survey respon-
dents. These will include members of national and inter-
national cancer societies, whose membership include 
practitioners from primary, community and secondary 
care settings, such as the British Oncology Pharmacy 
Association, UK Oncology Nursing Society and Clin-
ical Oncology Society of Australia, and research and 
Table 1 Review inclusion and exclusion criteria
Inclusion criteria
P—Population Practitioners, for example, doctors, nurses, pharmacists, allied health professionals, supporting 
self- management in adults living with and beyond cancer.
Patient, caregiver or manager perspectives on practitioner implementation of support of self- 
management consultations in adults living with and beyond cancer.
I—intervention Methods that promote the uptake of self- management support interventions or the provision of 
self- management support programmes, targeted to adults (>18 years) living with cancer in the post 
treatment/survivor stage of the cancer pathway.
C—Comparator None.
O—Outcomes Outcomes of interest will depend on the nature of the intervention, but could include:
Practitioners, for example, knowledge/skills/behaviours needed to support self- management and 
signposting patients.
Patients, for example, adjustments/acceptance of self- management, shared decision making, 
relationships with practitioners.
Process or implementation outcomes, for example, health service use, change in care delivery.
H—Healthcare context Any healthcare setting that provides care to adult cancer populations, for example, hospital, 
ambulatory care, outpatient care, community services/organisations, primary care practice, digital 
(eg, telehealth, app- based or web- based).
Study design
 ► No restriction on study design.
 ► Include non- empirical sources (ie, grey literature), for example, opinion papers, books, guidelines, policies, editorials, 
dissertations and so on through citation searches and identification by the review team and our stakeholders.
Exclusion criteria
 ► Self- management support interventions in the following phases of the cancer pathway: early detection, prevention, active 
treatment and end- of- life care.
 ► Self- management support interventions for managing consequences of radiotherapy or surgery only.
 ► Papers describing patient education, patient experiences or patient behaviour change that do not report health professional 
guided strategies to support behaviour change to manage problems or adjust to life after cancer treatment.
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advocacy groups involved with developing or evaluating 
self- management support services for people living with 
and beyond cancer.
We will send a link of the survey via email to invite poten-
tial participants to share their experiences. We will collect 
data on service design and delivery such as a description 
of the service, details about who developed and delivered 
the service, the patient groups targeted and details about 
what worked or not, and why. Completion of the survey 
will be voluntary. Only the research team will have access 
to the personal details of participants, which will be kept 
secure. Participants will be able to withdraw at any point, 
without giving a reason. All data will be destroyed or fully 
anonymised when no longer needed.
Step 4: selection and appraisal of evidence
We will use systematic methods for study screening and 
selection, using Preferred Reporting Items for Systematic 
Reviews and Meta- Analyses guidance.38 Two reviewers (KK 
and HW) will independently screen papers first by title 
and abstract and then full text. Papers in a non- English 
language will be excluded at title and abstract screening 
stages. Disagreements will be resolved by discussion with a 
third reviewer to ensure that there is consistency in paper 
inclusion. Depending on the number of papers retained, 
further refinement of the review scope may be decided 
by the review team. The review team will decide on new 
or revised selection criteria as the need for additional 
searches arises. These will likely depend on whether 
the additional studies can contribute to refinement of 
programme theories.
Inclusion criteria in realist reviews are whether the 
reported evidence has enough rigour and relevance 
to inform the development of CMOCs.21 Documents 
will be selected based on relevance to contributing to 
programme theory development or testing. We have 
developed criteria to rank the relevance of studies to 
help with the initial study selection process. Table 2 
summarises the ranking criteria for relevance that will 
allow the review team to distinguish between conceptu-
ally rich and weaker evidence for providing explanations 
for programme theory development. We will also review 
documents for rigour in terms of credibility and trustwor-
thiness, as outlined by the RAMESES standards.28 We will 
include studies if deemed ‘good enough’ by the review 
team in terms of robustness of the study and its conduct, 
by considering issues such as sample size, data collection, 
data analysis and claims made by study authors.22 Real-
ists argue that the traditional evidence hierarchy is not 
applicable when undertaking realist reviews or evalua-
tions.27 39 Useful causal information can arise from seem-
ingly poor quality studies that can provide rich insights 
for programme theory development.39 We will hence 
consider evidence of lesser quality if relevant for devel-
oping our programme theories.
Step 5: data extraction and synthesis
We will develop and pilot a bespoke Excel data extraction 
form. Data will be independently extracted by two 
reviewers and will include the following: study aims, 
design and methods, study participants (eg, people living 
with and beyond cancer, healthcare practitioners), study 
outcomes and information relevant to programme theo-
ries and emerging CMOCs. As per the realist approach, 
data will focus on author explanations and discussions 
about how an intervention was assumed to work or not. 
Table 2 Criteria to rank likely relevance of study to theory development
High relevance  ► Relates to adults living with and beyond cancer and describes the implementation of a self- 
management support activity initiated by practitioners or targeting practitioner behaviour change.
 ► Relates to supporting people living with and beyond cancer and describes training of practitioners in 
providing self- management support.
 ► Relates to supporting people living with and beyond cancer and includes description of practitioner 
views and experiences of self- management support.
 ► Describes studies on the perspectives of patients, caregivers or managers on practitioner 




 ► Relates to people living with and beyond cancer and includes description of patient experience of 
interacting with practitioners supporting self- management.
 ► Describes experiences of people living with and beyond cancer who have been provided with self- 
management support.
 ► Describes implementation of practitioner initiated self- management support in chronic diseases 
(including cancer).
Low relevance  ► Self- management support in people living with and beyond cancer described but involvement of 
practitioner in its delivery is unclear.
 ► Describes implementation of practitioner- led self- management support activity during other stages of 
the cancer journey (ie, not the survivorship stage).
 ► Quantitative data on self- management support intervention.
 ► Describes self- management support needs of people living with and beyond cancer.
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Individual papers may include segments that contribute 
to the different parts of a programme theory and there-
fore may need several readings to extract applicable data.
Sections of relevant text from papers and the online 
survey will be coded and imported into the Excel data 
extraction form. Some codes will originate from the 
papers and the online survey (inductive codes) and others 
from the initial programme theories (deductive codes). 
Coded text will be based on whether the evidence refers 
to context (C), mechanism (M) and/or outcome (O).
We will extract and code data from qualitative, quan-
titative and mixed methods studies separately. The 
extracted coded text from different study designs will 
then be synthesised together according to the relation-
ship between contexts, mechanisms and outcomes and to 
identify any emerging patterns of contexts and outcomes 
and the possible mechanisms.22 40 Data synthesis will 
involve reflection and discussion among the review team. 
We will question the integrity of each programme theory 
by examining if it is supported by empirical evidence, 
adjudicate between competing programme theories, 
consider the same programme theory in different 
settings and compare the programme theories to prac-
tical experiences of practitioners and patients.40 We will 
further attempt to link our programme theories to the 
TDF or another formal theory that may help to explain 
the patterns emerging from the CMOCs. We will use data 
from the papers and online survey to confirm, refute or 
refine the programme theories.
We will convene a workshop, to discuss our findings 
with stakeholders, which include practitioners, patients, 
caregivers and policymakers. The final output of the 
review will be a refined theory, called a middle- range 
theory that will highlight the key contextual factors 
and mechanisms involved in interventions, delivered 
by practitioners, to support self- management in people 
living with and beyond cancer. It is important to recog-
nise that this review will focus on a subset of prioritised 
programme theories, resulting in a middle- range theory 
that will represent partial knowledge. This potential 
limitation of realist reviews is widely accepted due to 
the restricted ground that can be covered by any single 
review.21
We will combine published data with real- world expe-
riences. Where interventions have been implemented 
widely, this innovative strategy may offer a methodolog-
ical advancement over the traditional exclusive use of 
published/grey literature in a realist review. Combining 
this real- world experience with published data may 
provide clearer insights into the mechanisms that 
operate in particular contexts to produce outcomes. 
Our findings will be used to inform future work to 
co- design an intervention targeted at practitioners to 
support people living with and beyond cancer to self- 
manage the long- term consequences of systemic anti-
cancer therapy.
PATIENT AND PUBLIC INVOLVEMENT
Members of the public were not involved in development 
of this protocol.
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